Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer

NCT00482807 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: bicalutamide
DRUG: docetaxel
DRUG: goserelin
RADIATION: intensity-modulated radiation therapy

Sponsor

University of Nebraska

Collaborators

[object Object]